Skip to main content
. 2021 Dec 6;8:757591. doi: 10.3389/fcvm.2021.757591

Figure 1.

Figure 1

OxLDL upregulated Grp94 level and HCP1 inhibited oxLDL-induced viability reduction in HUVECs. (A) Protein levels of Grp94 were detected after treatment with nLDL (50 μg/ml) or oxLDL (50 μg/ml) for the indicated time in HUVECs. Data are mean ± SEM; *p < 0.05, ***p < 0.001; n = 3. (B) Viability of HUVECs treated with nLDL (50 μg/ml) or oxLDL (50 μg/ml) with or without HCP1 (0.5, 1, 2 μM) for 48 h. Data are mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, NS p > 0.05; n = 5. Statistical analyses were performed using one-way ANOVA.